OXYGENTA PHARMACEUTICAL
OXYGENTA PHARMACEUTICAL Share Price Chart
OXYGENTA PHARMACEUTICAL last traded at ₹48.02 (2026-10-13). Over the past month the stock moved -10.7%, three months the stock moved -2.8%, year the stock moved -31.8%. Its closing range over 52 weeks is ₹46.66 – ₹67.50, with the latest close 28.9% below the high.
Closing prices up to 2026-10-13.
About OXYGENTA PHARMACEUTICAL
Incorporated in 1990, Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine Chemicals.
BusinessOverview[1] Oxygenta Pharmaceutical Limited (formerly S.S. Organics Limited) is a Telangana-based manufacturer of pharmaceutical APIs and intermediates. The company operates one pharmaceutical segment and is a 56.5%- owned subsidiary of unlisted Virupaksha Organics Limited
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), OXYGENTA PHARMACEUTICAL reported sales of ₹37.00 crore (+144.5%) and net profit of ₹-2.10 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 37.00 | 0.55 | 1.49 | -2.10 | -0.57 |
| Mar 2026 | 49.61 | 0.12 | 0.24 | -1.70 | -0.46 |
| Dec 2025 | 33.93 | -4.08 | -12.02 | -4.84 | -1.31 |
| Sep 2025 | 14.30 | -4.57 | -31.96 | -4.93 | -1.33 |
| Jun 2025 | 15.13 | -6.83 | -45.14 | -6.11 | -1.65 |
| Mar 2025 | 49.47 | -1.68 | -3.40 | -2.15 | -0.58 |
| Dec 2024 | 33.21 | -4.36 | -13.13 | -3.93 | -1.06 |
| Sep 2024 | 14.01 | -2.17 | -15.49 | -2.85 | -0.80 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +7.1% | +263.0% | +368.9% | +19.9% | +2.1% | +2.2% | +0.3% | +144.5% |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | -126.8% | – | – | – | – | – |
| EPS growth | – | – | -124.2% | – | – | – | – | – |
| OPM % | -15.5% | -13.1% | -3.4% | -45.1% | -32.0% | -12.0% | 0.2% | 1.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), OXYGENTA PHARMACEUTICAL reported sales of ₹113.00 crore (+3.7%) and net profit of ₹-18.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 113.00 | -15.00 | -14.00 | -18.00 | -4.75 |
| Mar 2025 | 109.00 | -10.00 | -9.00 | -10.00 | -2.79 |
| Mar 2024 | 40.00 | -10.00 | -24.00 | -3.00 | -1.04 |
| Mar 2023 | 31.00 | -7.00 | -23.00 | -12.00 | -8.15 |
| Mar 2022 | 61.00 | 1.00 | 2.00 | -1.00 | -0.43 |
| Mar 2021 | 52.00 | 4.00 | 7.00 | 3.00 | 2.87 |
| Mar 2020 | 14.00 | -8.00 | -57.00 | -6.00 | -5.68 |
| Mar 2019 | 21.00 | -2.00 | -10.00 | -3.00 | -3.19 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +61.5% | -33.3% | +271.4% | +17.3% | -49.2% | +29.0% | +172.5% | +3.7% |
| Operating profit growth | – | – | – | -75.0% | -800.0% | – | – | – |
| Net profit growth | – | – | – | -133.3% | – | – | – | – |
| EPS growth | – | – | – | -115.0% | – | – | – | – |
| OPM % | -10.0% | -57.0% | 7.0% | 2.0% | -23.0% | -24.0% | -9.0% | -14.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for OXYGENTA PHARMACEUTICAL.
Get Free AI Stock Analysis FREE →Latest News
-
Oxygenta Pharmaceutical reports standalone net loss of Rs 2.10 crore in the June 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of OXYGENTA PHARMACEUTICAL today?
OXYGENTA PHARMACEUTICAL shares were last quoted at ₹48.02 (-1.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of OXYGENTA PHARMACEUTICAL?
OXYGENTA PHARMACEUTICAL has a price-to-earnings (P/E) ratio of -13.51 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 53.33.
What is the 52-week high and low of OXYGENTA PHARMACEUTICAL?
The 52-week high of OXYGENTA PHARMACEUTICAL is ₹73.00 and the 52-week low is ₹43.00.
What is the market cap of OXYGENTA PHARMACEUTICAL?
The market capitalisation of OXYGENTA PHARMACEUTICAL is about ₹183.36 crore.
How did OXYGENTA PHARMACEUTICAL perform in its latest quarterly results?
In the latest quarter (Jun 2026), OXYGENTA PHARMACEUTICAL reported sales of ₹37.00 crore (+144.5%) and net profit of ₹-2.10 crore, compared with the same quarter last year.
Is OXYGENTA PHARMACEUTICAL a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, OXYGENTA PHARMACEUTICAL has 3-year profit growth of -28.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in OXYGENTA PHARMACEUTICAL?
Promoters hold about 56.54% of OXYGENTA PHARMACEUTICAL.
Which sector does OXYGENTA PHARMACEUTICAL belong to?
OXYGENTA PHARMACEUTICAL belongs to the Pharmaceuticals & Drugs sector.